<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03363711</url>
  </required_header>
  <id_info>
    <org_study_id>UPCC 26916</org_study_id>
    <nct_id>NCT03363711</nct_id>
  </id_info>
  <brief_title>AYA STEPS RCT: AYA Self-Management Via Texting, Education &amp; Plans for Survivors</brief_title>
  <official_title>AYA STEPS RCT: AYA Self-Management Via Texting, Education &amp; Plans for Survivors</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Abramson Cancer Center of the University of Pennsylvania</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Abramson Cancer Center of the University of Pennsylvania</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed project will leverage two programs of research at UPenn and CHOP that are&#xD;
      delivering technology-based interventions to adolescent and young adult (AYA) cancer&#xD;
      survivors.&#xD;
&#xD;
      In the proposed study, all AYA survivors will receive a care plan via a tool (Smart-ALACC).&#xD;
      They will then be randomized to receive (or not) a mobile health application (AYA STEPS) that&#xD;
      will provide tailored messages to enhance uptake of their care plan.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2017</start_date>
  <completion_date type="Anticipated">December 1, 2023</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Completed mobile data and questionnaires</measure>
    <time_frame>10 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">25</enrollment>
  <condition>Adolescent and Young Adult (AYA) Cancer Survivors</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>AYA STEPS</intervention_name>
    <description>a mobile health application</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        15-29 year olds with a history of malignant cancer diagnosis.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  AYA is 15-29 year old with a history of a malignant cancer diagnosis;&#xD;
&#xD;
          -  Completed cancer treatment and are currently in remission or receiving cancer&#xD;
             survivorship care;&#xD;
&#xD;
          -  Seen for follow-up oncology care at CHOP or Penn;&#xD;
&#xD;
          -  For AYA less than 18 years old, must have a caregiver to provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cognitive impairments that would limit AYA ability to independently care for health as&#xD;
             determined by the medical team.&#xD;
&#xD;
          -  Absence of the inclusion criteria&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>29 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Christine Hill-Kayser, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Abramson Cancer Center of the University of Pennsylvania</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Abramson Cancer Center of the University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>December 1, 2017</study_first_submitted>
  <study_first_submitted_qc>December 1, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 6, 2017</study_first_posted>
  <last_update_submitted>February 4, 2021</last_update_submitted>
  <last_update_submitted_qc>February 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

